Ms. Li Yi, Director of Market Access of Innogen Pharmaceutical, has more than 15 years experience in market access and patient innovation payment programs in the pharmaceutical industry. She has worked in Servier, Takeda, and Roche Pharmaceuticals, and has rich experience in healthcare policy analysis and policy shaping, local medical insurance listing and government affairs, patient support programs and responsible for the integrated access strategies/portfolio strategy for innovative drugs（especially on oncology, neuroscience, and rare diseases areas，etc.） Ms. Li graduated from Peking University with a master’s degree in pharmaceutical administration and received her bachelor’s degree from West China Medical University, school of pharmacy.
Yi Li
